Enter a keyword or phrase to search all pages in this section:


Advanced search

Archive:

Looking for a previously published document in this section?

Class 4 Drug Alert (Caution in use): Solvay Healthcare Limited - Creon Micro Pancreatin 60.36mg Gastro-resistant Granules - EL (09)A/22

Document details:

Type: Drug Alert
Series No: EL (09)A/22
Audience: Healthcare professionals
Published:
Format: Electronic and paper
Size: A4
Pages: 2
Price: Free
ISBN/ISSN:
Author:
Copyright: Crown
   

Help viewing PDFs:

Please note: In October and November 2010, the MHRA moved from its Market Towers address to a new location on Buckingham Palace Road. Please go to the contact us section of the website for updated contact details.

DRUG ALERT

Class 4 medicines defect information
Caution in use
Distribute to pharmacy level
14 July 2009 EL (09)A/22 Our ref:  MDR 09-07/09

Dear Healthcare Professional,

Solvay Healthcare Limited

Creon Micro Pancreatin 60.36mg Gastro-resistant Granules

PL 00512/0179

Batch Number Expiry Date Pack Size First Distributed
44697 11/2010 20g 30 June 2009

Solvay Healthcare Limited has informed us that the lid on bottles of Creon Micro Pancreatin 60.36mg Gastro-resistant Granules from the above batch may spontaneously open, either fully or partially. The product is only affected once the tamper evident strip has been removed.

To avoid stock disruption, this batch is not being recalled. Solvay Healthcare Limited hope to have a new batch available during week commencing 03 August 2009. In the meantime, please inform recipients of this batch of the issue, including those patients who may already have received it.  

Patients/carers are advised to tape the lid securely shut once the tamper evident strip is removed. For extra security, the whole bottle may be placed in a resealable plastic bag, although any granules which escape should be discarded. Once opened, product from this batch should only be used for 14 days. Solvay Healthcare Limited has informed us that they will provide any additional stock required due to this issue free of charge.

For further information please contact the Solvay Healthcare Limited Medical Information Unit on 02380 467000 or e-mail medinfo.shl@solvay.com.

Recipients of this Drug Alert should bring it to the attention of relevant contacts by copy of this letter. Primary Care Trusts are asked to forward this to relevant clinics, General Practitioners and Community Pharmacists.

Yours faithfully

Alison Bunce
Pharmaceutical Assessor, DMRC

 

MHRA Distribution (further recipients by cascade):

Regional Contacts for NHS Trusts and Provider Units
Chief Pharmacists: England, Scotland, Wales, Northern Ireland
Prison Health Policy Unit (DH)
Chief Pharmacists: Jersey, Guernsey, Alderney, Sark, Isle of Man, Gibraltar
Special Hospitals
Healthcare Commission for distribution to Independent Health Care Establishments
Primary Care Trusts (England)

Page last modified: 14 July 2009